|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3800 AUD | -1.30% |
|
+1.33% | -41.54% |
| Market Cap | 11Cr 7.95Cr 6.94Cr 6.41Cr 5.91Cr 11Cr 765.24Cr 77Cr 30Cr 374.78Cr 30Cr 29Cr 1.29TCr | P/E 2026 * |
-6.33x | P/E 2027 * | -2.38x |
|---|---|---|---|---|---|
| Enterprise Value | 12Cr 8.51Cr 7.44Cr 6.86Cr 6.33Cr 12Cr 819.5Cr 82Cr 32Cr 401.36Cr 32Cr 31Cr 1.38TCr | EV / Sales 2026 * |
12.8x | EV / Sales 2027 * | 20.6x |
| Free-Float |
60.61% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -1.30% | ||
| 1 week | +1.33% | ||
| Current month | -6.17% | ||
| 1 month | -23.23% | ||
| 3 months | -32.14% | ||
| 6 months | -45.71% | ||
| Current year | -41.54% |
| 1 week | 0.36 |  | 0.39 |
| 1 month | 0.36 | | 0.51 |
| Current year | 0.36 | | 0.73 |
| 1 year | 0.34 | | 0.73 |
| 3 years | 0.28 | | 0.78 |
| 5 years | 0.28 | | 1.38 |
| 10 years | 0.13 | | 1.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
James Graham
CEO | Chief Executive Officer | - | 28/08/2020 |
Justin Reynolds
DFI | Director of Finance/CFO | - | - |
Michele Dilizia
CTO | Chief Tech/Sci/R&D Officer | - | 30/09/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Michele Dilizia
BRD | Director/Board Member | - | 01/10/2012 |
James Graham
BRD | Director/Board Member | - | 01/05/2012 |
| Director/Board Member | - | 01/09/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 24/02/26 | Expiration | Chief Executive Officer | 22,50,000 | 0.7781% | ||
| 14/10/25 | Expiration | Chief Executive Officer | 7,45,962 | 0.3217% | ||
| 21/11/24 | Buy | Chairman | 26,50,000 | 1.1429% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.30% | +1.33% | +13.43% | -41.98% | 8.07Cr | |
| +0.31% | -1.18% | +54.25% | +162.69% | 1,04300Cr | |
| +1.15% | -1.58% | +55.19% | +59.00% | 60TCr | |
| +0.45% | +3.20% | +33.76% | +89.89% | 45TCr | |
| +0.78% | -0.71% | +30.04% | +24.61% | 33TCr | |
| +1.41% | +0.58% | +33.92% | +47.20% | 28TCr | |
| -0.27% | -1.87% | +22.13% | +23.47% | 26TCr | |
| -2.40% | -0.23% | +21.56% | +59.12% | 20TCr | |
| -1.12% | +3.93% | +24.02% | +74.15% | 17TCr | |
| -0.38% | +3.56% | +1.83% | -30.20% | 14TCr | |
| Average | -0.19% | -0.35% | +29.01% | +46.79% | 34.77TCr | |
| Weighted average by Cap. | +0.25% | -1.82% | +39.90% | +84.27% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 95.58L 66.74L 58.33L 53.82L 49.61L 93.5L 64Cr 6.43Cr 2.53Cr 31Cr 2.51Cr 2.45Cr 108.36Cr | 81.91L 57.2L 49.98L 46.12L 42.51L 80.13L 55Cr 5.51Cr 2.17Cr 27Cr 2.15Cr 2.1Cr 93Cr |
| Net income | -1.87Cr -1.3Cr -1.14Cr -1.05Cr -96.98L -1.83Cr -125.65Cr -13Cr -4.95Cr -62Cr -4.9Cr -4.79Cr -211.84Cr | -4.72Cr -3.3Cr -2.88Cr -2.66Cr -2.45Cr -4.62Cr -317.38Cr -32Cr -12Cr -155.44Cr -12Cr -12Cr -535.09Cr |
| Net Debt | 80.7L 56.35L 49.24L 45.44L 41.89L 78.95L 54Cr 5.43Cr 2.14Cr 27Cr 2.12Cr 2.07Cr 91Cr | 5.46Cr 3.81Cr 3.33Cr 3.08Cr 2.84Cr 5.34Cr 367.34Cr 37Cr 14Cr 179.91Cr 14Cr 14Cr 619.33Cr |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/26/17 | A$0.3800 | -1.30% | 1,55,988 |
| 16/26/16 | A$0.3850 | +5.48% | 1,95,033 |
| 15/26/15 | A$0.3650 | -5.19% | 1,50,075 |
| 14/26/14 | A$0.3850 | -1.28% | 4,06,483 |
| 13/26/13 | A$0.3900 | +1.30% | 3,54,511 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- RCE Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
